Vaxart to Announce Q4 Earnings on March 12
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Source: seekingalpha
- Earnings Announcement Schedule: Vaxart (VXRT) is set to release its Q4 2023 earnings on March 12 after market close, with consensus EPS estimate at -$0.07 and revenue estimate at $35.95 million, reflecting cautious market sentiment regarding the company's financial performance.
- Historical Performance Review: Over the past two years, Vaxart has beaten EPS and revenue estimates 63% of the time, indicating a degree of stability in its financial results that could positively influence investor confidence.
- Industry Conference Participation: Vaxart presented at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, enhancing its visibility among investors and industry analysts, which may pave the way for future financing and collaboration opportunities.
- Market Analysis Dynamics: According to Seeking Alpha's Quant Rating, Vaxart's market performance contrasts with strong buy stocks like Avino Silver & Gold and Harmony Gold, highlighting differing market perceptions of its growth potential.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
